AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Sodium Chloride Intravenous Infusion BP 0.9% W/V

6 registrations across 3 African markets— 6 active

Markets with Sodium Chloride Intravenous Infusion BP 0.9% W/V

🇿🇲Zambia
3 registrations
3 active
🇹🇿Tanzania
2 registrations
2 active
🇷🇼Rwanda
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
Sodium Chloride Injection 0.9% BP
Solution for influsion
🇿🇲ZambiaKingphar Company Zambia LimitedactiveAug 2030
Sodium Chloride I.V
Solution For Infusion
🇿🇲ZambiaOtsuka Pharmaceutical India Private LimitedactiveJul 2030
NS - 500 Sodium Chloride BP Infusion
solution for IV injection
🇿🇲ZambiaAbacus Parenteral Drugs Ltd (APDL)activeOct 2029
NS
Intravenous infusion
🇷🇼RwandaAXA PARENTERALS LIMITED,activeDec 2027
MEHECO
Solution for Infusion
🇹🇿TanzaniaChina Meheco Corporationactive—
NS
Solution For Infussion
🇹🇿TanzaniaKAIRUKI PHARMACEUTICALS INDUSTRY LIMITEDactive—

Sodium Chloride Intravenous Infusion BP 0.9% W/V in Africa — Regulatory Overview

Sodium Chloride Intravenous Infusion BP 0.9% W/V is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zambia, Tanzania, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.